Malignant hypertension laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Malignant hypertension}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==...")
 
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Malignant hypertension}}
{{Malignant hypertension}}
{{CMG}}
==Laboratory Findings==


Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
* [[Complete blood count]]
* [[Electrolyte]]s
 
* [[Coagulation]] profile
 
* [[Urinalysis]]
 
* [[Cardiac enzymes]]
 
* urinary [[catecholamines]]
 
* [[Thyroid-stimulating hormone]] (TSH)
 
* 24-hour urine collection for [[vanillylmandelic acid]] (VMA) and catecholamines.
* [[BUN]], [[creatinine]]
 
Urinalysis may reveal
 
* [[Proteinuria]]
 
* Microscopic [[hematuria]]
 
* RBC or [[hyaline cast]]s.
 
In patients with [[hyperaldosteronism]] (a secondary cause of hypertension), aldosterone promotes renal potassium wasting, resulting in low serum potassium.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Needs overview]]
[[Category:Medical emergencies]]
[[Category:Medical emergencies]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]

Latest revision as of 19:51, 22 February 2013

Malignant hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Malignant hypertension from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Malignant hypertension laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Malignant hypertension laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Malignant hypertension laboratory findings

CDC on Malignant hypertension laboratory findings

Malignant hypertension laboratory findings in the news

Blogs on Malignant hypertension laboratory findings

Directions to Hospitals Treating Malignant hypertension

Risk calculators and risk factors for Malignant hypertension laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Urinalysis may reveal

In patients with hyperaldosteronism (a secondary cause of hypertension), aldosterone promotes renal potassium wasting, resulting in low serum potassium.

References


Template:WikiDoc Sources